<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="11202">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00593372</url>
  </required_header>
  <id_info>
    <org_study_id>g1-10532-03-07</org_study_id>
    <nct_id>NCT00593372</nct_id>
  </id_info>
  <brief_title>Treatment of Language and Memory in Patients With Alzheimer's Disease</brief_title>
  <official_title>Treatment of Language and Memory in Patients With Alzheimer's Disease: A Comparison Between Drug Therapy and Drug Therapy Plus Behavioral Intervention</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Arkansas</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Arkansas</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to collect data on the effects of behavioral interventions for
      memory and communication deficits in persons taking cholinesterase inhibitors compared with
      the effects of cholinesterase inhibitors alone. Initial testing will include a written case
      history, tests of communication skills, and interviews with the participants, family, and
      staff caregivers to help select potential goals for treatment. Participants will be randomly
      selected to participate in Group A (control) or Group B (intervention). Group A will use a
      Caregiver Checklist for eight weeks to identify any increase or decrease in the occurrence
      of the identified communication deficits. Group B will have 16 treatment sessions by a
      Speech Language Pathologist during the eight-week period. A post test will be administered
      to all participants.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with dementia suffer from a variety of cognitive-linguistic deficits, including
      attention, orientation, memory, anomia, and pragmatics. Behavioral treatment of these
      deficits falls within the domain of speech-language pathology. While no efficacy studies
      have emerged to demonstrate the benefit of speech-language therapy for individuals who
      suffer Alzheimer's disease (AD), data are emerging which support the positive effects of
      memory and communication intervention in this population. Phase I and Phase II
      investigations are beginning to provide evidence that such intervention should focus on the
      development of innovative strategies to help patients compensate for the disabilities
      resulting from the disease rather than on traditional rehabilitation of impairment. The
      benefits of cholinesterase inhibitors for improving cognitive function in persons with AD
      have been demonstrated, and data continue to emerge on specific drugs and specific changes
      in cognitive processes. The purpose of the proposed investigation would be to collect pilot
      data on the effects of behavioral intervention for memory and communication deficits in
      conjunction with cholinesterase inhibitors, as compared with the effects of cholinesterase
      inhibitors used in isolation. Participants will be individuals with AD who are recruited
      from the Alzheimer's Disease Center at The University of Arkasas for Medical Sciences
      Medical Center. All participants will be taking cholinesterase inhibitors, and half of all
      participants will be randomly selected to receive intervention by a speech-language
      pathologist. Intervention will consist of 16 treatment sessions (one hour each) over a two
      month period and will focus on strategies for enhancing memory and functional communication.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2003</start_date>
  <completion_date type="Actual">April 2010</completion_date>
  <primary_completion_date type="Actual">April 2010</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Number of Successful Memory Tasks Completed Over Study Period.</measure>
    <time_frame>8 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Successful memory tasks are those memory tasks (such as &quot;where do I keep my keys&quot;) that participants are able to consistently respond to.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change on Mini-Mental State Examination</measure>
    <time_frame>End of Study</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">11</enrollment>
  <condition>Alzheimer's Disease. Middle Stage.</condition>
  <arm_group>
    <arm_group_label>I</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Drug Plus Behavioral Therapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>II</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Drug Therapy Only</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Spaced Retrieval Training</intervention_name>
    <description>Increasing time to remember important information.</description>
    <arm_group_label>I</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Alzheimer's Disease (middle stage)

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gary H McCullough, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Arkansas</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UAMS Medical Center</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72035</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2010</verification_date>
  <lastchanged_date>July 27, 2010</lastchanged_date>
  <firstreceived_date>January 2, 2008</firstreceived_date>
  <firstreceived_results_date>April 27, 2010</firstreceived_results_date>
  <responsible_party>
    <name_title>Gary H. McCullough</name_title>
    <organization>UArkansas</organization>
  </responsible_party>
  <keyword>Alzheimer's Disease</keyword>
  <keyword>Memory</keyword>
  <keyword>Treatment</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Alzheimer Disease</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Spaced Retrieval Therapy</title>
          <description>Participants continue on current medication but participate in spaced retrieval memory training, as well.</description>
        </group>
        <group group_id="P2">
          <title>Continuing Medication Only</title>
          <description>Participants continue on current medication and are assessed at beginning and end of study duration.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="8">Eight enrolled in behavioral treatment.</participants>
                <participants group_id="P2" count="3">Three evaluated but only maintained medical treatment.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="8">Eight completed behavioral treatment.</participants>
                <participants group_id="P2" count="3">Three evaluated and completed protocol.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Spaced Retrieval Therapy</title>
          <description>Participants continue on current medication but participate in spaced retrieval memory training, as well.</description>
        </group>
        <group group_id="B2">
          <title>Continuing Medication Only</title>
          <description>Participants continue on current medication and are assessed at beginning and end of study duration.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="8"/>
                <measurement group_id="B2" value="3"/>
                <measurement group_id="B3" value="11"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>&lt;=18 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Between 18 and 65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="1"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="1"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>&gt;=65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="7"/>
                <measurement group_id="B2" value="3"/>
                <measurement group_id="B3" value="10"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="74" spread="5"/>
                <measurement group_id="B2" value="72" spread="3"/>
                <measurement group_id="B3" value="72" spread="6"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="2"/>
                <measurement group_id="B2" value="2"/>
                <measurement group_id="B3" value="4"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="6"/>
                <measurement group_id="B2" value="1"/>
                <measurement group_id="B3" value="7"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>United States</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="8"/>
                <measurement group_id="B2" value="3"/>
                <measurement group_id="B3" value="11"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Successful Memory Tasks Completed Over Study Period.</title>
        <description>Successful memory tasks are those memory tasks (such as &quot;where do I keep my keys&quot;) that participants are able to consistently respond to.</description>
        <time_frame>8 weeks</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Spaced Retrieval Therapy</title>
            <description>Participants continue on current medication but participate in spaced retrieval memory training, as well.</description>
          </group>
          <group group_id="O2">
            <title>Continuing Medication Only</title>
            <description>Participants continue on current medication and are assessed at beginning and end of study duration.</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="8"/>
                  <measurement group_id="O2" value="3"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Number of Successful Memory Tasks Completed Over Study Period.</title>
            <description>Successful memory tasks are those memory tasks (such as &quot;where do I keep my keys&quot;) that participants are able to consistently respond to.</description>
            <units>memory tasks</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="5"/>
                  <measurement group_id="O2" value="0"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change on Mini-Mental State Examination</title>
        <time_frame>End of Study</time_frame>
        <safety_issue>No</safety_issue>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Spaced Retrieval Therapy</title>
          <description>Participants continue on current medication but participate in spaced retrieval memory training, as well.</description>
        </group>
        <group group_id="E2">
          <title>Continuing Medication Only</title>
          <description>Participants continue on current medication and are assessed at beginning and end of study duration.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>1</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Recruitment of participants was the major limitation of the trial. Alzheimer's patients at facility were asked to participate in so many studies, that participation in this one was challenging.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Gary McCullough</name_or_title>
      <organization>UAMS Medical Center</organization>
      <phone>501-852-7886</phone>
      <email>garyhmccullough@uams.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
